Answers are grounded in this paper and cite their sources.
The A1C metric has been the gold standard for assessing glycemia for decades. This biologic assay, based on averaging, is fraught with limitations and may be giving way to more holistic approaches. This article reviews glycemic time in range as the new standard for assessing patients with continuous glucose monitoring data. Information from the International Consensus Group on Time in Range will be summarized.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: